Literature DB >> 16973593

Mobilization of full-length Semliki Forest virus replicon by retrovirus particles.

Eric Piver1, Christine Collin, Noémie Renault, Thierry Bru, Jean-Christophe Pagès.   

Abstract

Conciliating biosafety with efficient gene transfer remains a constant concern in the development of retroviral vectors. Semliki Forest virus (SFV) replicons allow important retroviral vector production with interesting features. It is noteworthy that retroviruses have the ability to package Psi+ and, to some extent, Psi- cellular RNAs. Therefore, it was important to study the retroviral transfer of highly abundant SFV genomes expressing retroviral proteins. Here, we show that full-length SFV-vector replicons, with or without Psi, are efficiently packaged into retrovirus particles. Mechanistically, our data suggest that SFV packaging is the sum of its retroviral nucleocapsid-dependent recruitment together with a passive hijacking of membrane-anchored SFV replicon. A direct consequence of this phenomenon is the formation of particles harboring autonomous replicative abilities and contaminating vector preparations. Importantly, we confirm that retroviral SFV mobilization is not an exclusive feature of murine gamma retroviruses, since it is also observed using lentivectors.

Entities:  

Mesh:

Year:  2006        PMID: 16973593      PMCID: PMC1617220          DOI: 10.1128/JVI.00664-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Simplified generation of high-titer retrovirus producer cells for clinically relevant retroviral vectors by reversible inclusion of a lox-P-flanked marker gene.

Authors:  Rainer Loew; Nathalie Selevsek; Boris Fehse; Dorothee von Laer; Christopher Baum; Axel Fauser; Klaus Kuehlcke
Journal:  Mol Ther       Date:  2004-05       Impact factor: 11.454

Review 2.  Toolbox for retrovectorologists.

Authors:  J C Pagès; Thierry Bru
Journal:  J Gene Med       Date:  2004-02       Impact factor: 4.565

3.  Structural basis for packaging the dimeric genome of Moloney murine leukaemia virus.

Authors:  Victoria D'Souza; Michael F Summers
Journal:  Nature       Date:  2004-09-30       Impact factor: 49.962

4.  Retroviral pseudotransduction for targeted cell manipulation.

Authors:  Melanie Galla; Elke Will; Janine Kraunus; Lei Chen; Christopher Baum
Journal:  Mol Cell       Date:  2004-10-22       Impact factor: 17.970

5.  Role of murine leukemia virus nucleocapsid protein in virus assembly.

Authors:  Delphine Muriaux; Sylvain Costes; Kunio Nagashima; Jane Mirro; Ed Cho; Stephen Lockett; Alan Rein
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

6.  Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector.

Authors:  Min Guan; Juan R Rodriguez-Madoz; Pilar Alzuguren; Celia Gomar; M Gabriela Kramer; Stefan Kochanek; Jesus Prieto; Cristian Smerdou; Cheng Qian
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

7.  Semliki Forest virus expression system: production of conditionally infectious recombinant particles.

Authors:  P Berglund; M Sjöberg; H Garoff; G J Atkins; B J Sheahan; P Liljeström
Journal:  Biotechnology (N Y)       Date:  1993-08

8.  Vesicular stomatitis virus glycoprotein: a transducing coat for SFV-based RNA vectors.

Authors:  Fabien Dorange; Eric Piver; Thierry Bru; Christine Collin; Philippe Roingeard; Jean-Christophe Pagès
Journal:  J Gene Med       Date:  2004-09       Impact factor: 4.565

9.  LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.

Authors:  S Hacein-Bey-Abina; C Von Kalle; M Schmidt; M P McCormack; N Wulffraat; P Leboulch; A Lim; C S Osborne; R Pawliuk; E Morillon; R Sorensen; A Forster; P Fraser; J I Cohen; G de Saint Basile; I Alexander; U Wintergerst; T Frebourg; A Aurias; D Stoppa-Lyonnet; S Romana; I Radford-Weiss; F Gross; F Valensi; E Delabesse; E Macintyre; F Sigaux; J Soulier; L E Leiva; M Wissler; C Prinz; T H Rabbitts; F Le Deist; A Fischer; M Cavazzana-Calvo
Journal:  Science       Date:  2003-10-17       Impact factor: 47.728

Review 10.  Safety issues related to retroviral-mediated gene transfer in humans.

Authors:  K Cornetta; R A Morgan; W F Anderson
Journal:  Hum Gene Ther       Date:  1991       Impact factor: 5.695

View more
  3 in total

1.  A novel self-replicating chimeric lentivirus-like particle.

Authors:  Christy K Jurgens; Kelly R Young; Victoria J Madden; Philip R Johnson; Robert E Johnston
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

2.  Influence of untranslated regions on retroviral mRNA transfer and expression.

Authors:  Anne Prel; Luc Sensébé; Jean-Christophe Pagès
Journal:  BMC Biotechnol       Date:  2013-04-16       Impact factor: 2.563

3.  Highly efficient in vitro and in vivo delivery of functional RNAs using new versatile MS2-chimeric retrovirus-like particles.

Authors:  Anne Prel; Vincent Caval; Régis Gayon; Philippe Ravassard; Christine Duthoit; Emmanuel Payen; Leila Maouche-Chretien; Alison Creneguy; Tuan Huy Nguyen; Nicolas Martin; Eric Piver; Raphaël Sevrain; Lucille Lamouroux; Philippe Leboulch; Frédéric Deschaseaux; Pascale Bouillé; Luc Sensébé; Jean-Christophe Pagès
Journal:  Mol Ther Methods Clin Dev       Date:  2015-10-21       Impact factor: 6.698

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.